4//SEC Filing
Inrig Jula 4
Accession 0001415889-25-019108
CIK 0001438533other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 5:28 PM ET
Size
5.3 KB
Accession
0001415889-25-019108
Insider Transaction Report
Form 4
Inrig Jula
CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
2025-07-01$14.65/sh−815$11,940→ 88,787 total
Footnotes (1)
- [F1]This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of additional shares to cover the tax obligation that occurred upon the vesting of performance-based restricted stock units (PSUs) that vested in February 2025.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001902368
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 5:28 PM ET
- Size
- 5.3 KB